Spondarthropathies are most often diagnosed on the basis of clinical a
nd radiological symptoms. Since the currently available laboratory dia
gnostic tests have been unable to make a significant contribution to t
he diagnosis of ankylosing spondylitis and other spondarthropathies, o
ur research group developed at the end of the 70 s a new serodiagnosti
c test system. This test is based on polytene chromosomes from Drosoph
ila melanogaster, and shows a specific immunofluorescence pattern with
sera of patients with ankylosing spondylitis. This immunofluorescence
pattern is a relevant indicator for a possible autoimmune background
of spondarthropathies. From the early 90s onwards, more than 1100 pati
ents with different rheumatic diseases have been examined using a newl
y developed ELISA test system which employs a recombinant 28 kDA Droso
phila antigen. This ELISA gives a specificity of approximately 90%, an
d a sensitivity of approximately 30% for the diagnosis of spondylarthr
opathy. Thus we have shown, for the first time, a specific laboratory
parameter for this group of diseases.